Risk Behavior Harm Reduction: Preventing Acquisition and Transmission of HIV and HCV

July 09, 2017
HIV HCV Curriculum Logo

This lesson focuses on primary prevention of HCV, including harm reduction education related to drug use, sexual behavior, tattooing, and hormone/silicone injection practices.

Download Slides

  1. Harm reduction: An approach to reducing risky health behaviours in adolescents. Paediatrics & Child Health. 2008;13(1):53-56.
  2. What is harm reduction? Harm Reduction International Website. Accessed May 19, 2017.
  3. Centers for Disease Control and Prevention. HIV Transmission. Updated December 21, 2016. Accessed June 15, 2017.
  4. Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. AIDS Read. 2000 Jul;10(7):410-7.
  5. Abdala N, Reyes R, Carney JM, Heimer R. Survival of HIV-1 in syringes: effects of temperature during storage. Subst Use Misuse. 2000 Aug;35(10):1369-83.
  6. Doerrbecker J, Friesland M, Ciesek S, et al. Inactivation and survival of hepatitis C virus on inanimate surfaces. J Infect Dis. 2011 Dec 15;204(12):1830-8.
  7. Paintsil E, Binka M, Patel A, Lindenbach B, Heimer R. Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission. J Infect Dis. 2014 Apr 15;209(8):1205-11.
  8. Paintsil E, He H, Peters C, Lindenbach B, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis. 2010 Oct 1;202(7):984-90
  9. Binka M, Paintsil E, Patel A, Lindenbach B, Heimer R. Survival of hepatitis c virus in syringes is dependent on the design of the syringe-needle and dead space volume. PLoS One. 2015 Nov 4;10(11):e0139737.
  10. Doerrbecker J, Behrendt P, Mateu-Gelabert P, et al. Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. J Infect Dis. 2013 Jan 15;207(2):281-7.
  11. Palmateer N, Hutchinson S, McAllister G, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014 Jan;21(1):25-32.
  12. Centers for Disease Control and Prevention. HIV Risk Reduction Tool: Injecting Drugs. Accessed June 15, 2017.
  13. Centers for Disease Control and Prevention. Syringe Services Programs. Updated May 17, 2016. Accessed April 11, 2017.
  14. Oramasionwu C, Johnson T, Zule W, Carda-Auten J, Golin C. Using pharmacies in a structural intervention to distribute low dead space syringes to reduce HIV and HCV transmission in people who inject drugs. Am J Public Health. 2015 Jun;105(6):1066-71.
  15. Tortu S, McMahon J, Pouget E, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse. 2004 Jan;39(2):211-24.
  16. Des Jarlais DC, Arasteh K, McKnight C, Ringer M, Friedman SR. Syringe exchange, injecting and intranasal drug use. Addiction. 2010 Jan;105(1):155-8.
  17. Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 2012 Apr;54(8):1167-78.
  18. Centers for Disease Control and Prevention. HIV Risk Reduction Tool: Sexual Behaviors.  June 15, 2017.
  19. van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009 May;136(5):1609-17.
  20. Hu J, Gu X, Tao X, et al. Prevalence and trends of HIV, syphilis, and HCV in migrant and resident men who have sex with men in Shandong, China: results from a serial cross-sectional study. Plos One. 2017 Jan 19;12(1):e0170443.
  21. Nadol P, O'Connor S, Duong H, et al. High hepatitis C virus (HCV) prevalence among men who have sex with men (MSM) in Vietnam and associated risk factors: 2010 Vietnam Integrated Behavioural and Biologic Cross-Sectional Survey. Sex Transm Infect. 2016 Apr 4. pii: sextrans-2015-052518. [Epub ahead of print]
  22. Centers for Disease Control and Prevention. HIV Risk Reduction Tool: Injecting Silicone (Pumping Silicone). Accessed June 15, 2017.
  23. Siddharta A, Pfaender S, Malassa A, et al. Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs. Sci Rep. 2016 Nov 18;6:36619.